Humana (HUM)
(Delayed Data from NYSE)
$311.41 USD
-4.57 (-1.45%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $312.00 +0.59 (0.19%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Price, Consensus and EPS Surprise
HUM 311.41 -4.57(-1.45%)
Will HUM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HUM
Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Humana (HUM) Tops Q1 Earnings and Revenue Estimates
Other News for HUM
Buy Rating Affirmed for Humana Despite Earnings Forecast Adjustment: Growth and Fundamentals Remain Strong
Humana’s Strong Q1 Performance and Cost Efficiency Bolster Buy Rating Despite 2025 Uncertainties
TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
Humana Healthy Horizons Commits $500K to Improve Health of Louisianians
Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies